13F History
Schedule 13D/G History
Other Reports

GREAT POINT PARTNERS LLC (Ortav Yehudai, Lillian Nordahl, Mr. David Kroin, Dr. Jeffrey R. Jay) - Significant Ownership

Notable people: Ortav Yehudai, Lillian Nordahl, Mr. David Kroin, Dr. Jeffrey R. Jay
Signature - Title: Dr. Jeffrey R. Jay, M.D. - Senior Managing Member
Location: Greenwich, CT
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by GREAT POINT PARTNERS LLC.

Significant Ownership of GREAT POINT PARTNERS LLC

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
UNCY	Unicycive Therapeutics, Inc.	Common Stock, par value $0.001 per share	9.99%	$6.77M		11.5M		Great Point Partners, LLC	Dec 31, 2024
PMN	ProMIS Neurosciences Inc.	Common Shares, no par value per share	9.99%	$2.63M		3.33M		Great Point Partners, LLC	Dec 31, 2024
OPTN	OPTINOSE, INC.	Common Stock, $0.001 par value per share	8.47%	$4.84M		897K		Great Point Partners, LLC	Dec 31, 2024
OTLK	Outlook Therapeutics, Inc.	Common Stock, $0.001 par value per share	8.18%	$3.29M		2.22M		Great Point Partners, LLC	Dec 31, 2024
VTGN	Vistagen Therapeutics, Inc.	Common Stock, $0.001 par value per share	6.88%	$5.74M		2.06M		Great Point Partners, LLC	Dec 31, 2024
CNTX	Context Therapeutics Inc.	Common Stock	6.25%	$3.04M		4.68M		Great Point Partners, LLC	Dec 31, 2024
ZURA	ZURA BIO LIMITED	Class A Ordinary Shares, $0.0001 par value	4.86%	$4.06M		3.17M		Great Point Partners, LLC	Dec 31, 2024
NGNE	NEUROGENE INC.	Common Stock, par value $0.000001 per share	2.98%	$7.44M		443K		Great Point Partners, LLC	Dec 31, 2024

Showing 1 to 8 of 8 entries

Schedules 13D/G Reported by GREAT POINT PARTNERS LLC:

Showing 0 to 0 of 0 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.